SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Emmanuel A.) srt2:(1995-1999)"

Sökning: WFRF:(Emmanuel A.) > (1995-1999)

  • Resultat 1-3 av 3
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Blank, Vladimir D., et al. (författare)
  • Electric resistivity and  magnetoresistance of some superhard and ultrahard fullerites in the range 300-2K
  • 1999
  • Ingår i: AIP Conference Proceedings vol. 486. - Melville, NY : American Institute of Physics (AIP). - 1563969009 ; , s. 416-420
  • Konferensbidrag (refereegranskat)abstract
    • Electric resistivity and magnetoresistance were measured on samples with disordered structure synthesized from pure C60 and C70 at pressures in the range 8 - 12.5 GPa and temperature 900 - 1500 K. Different type of behaviour were observed: semimetallic and semiconducting, depending on the particular short-range order of the structure.
  •  
3.
  • Frey, Sharon, et al. (författare)
  • Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine
  • 1999
  • Ingår i: Journal of Infectious Diseases. - : Oxford University Press (OUP). - 0022-1899 .- 1537-6613. ; 180:6, s. 2018-2022
  • Tidskriftsartikel (refereegranskat)abstract
    • A randomized trial comparing 3 manufacturing consistency lots of a combination hepatitis A/hepatitis B vaccine to each other and to hepatitis A vaccine and hepatitis B vaccine given separately and concurrently was done to evaluate safety, tolerability, and immunogenicity. Healthy volunteers >/=11 years of age were divided into 4 groups. Each of 3 groups received a separate consistency lot of the combination vaccine, and 1 group received separate but concurrent injections of hepatitis A and hepatitis B vaccines. Injections were given at weeks 0 and 24. The combination vaccine was generally well tolerated. The hepatitis A portion of the combination vaccine produced clinically acceptable high seropositivity rates 4 and 52 weeks after the first injection. The hepatitis B portion of the vaccine did not produce clinically acceptable seropositivity rates 4 weeks after the second injection. Lack of antibody production may be attributed, at least in part, to immunologic interference.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-3 av 3

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy